» Articles » PMID: 37508055

Development of a Rainbow Trout () Intestinal Platform for Profiling Amino Acid Digestion and Absorption of a Complete Diet

Abstract

The ever-increasing number and variation of raw materials utilized to provide alternative feed formulations continues to allow for a more sustainable and flexible approach. Testing all these options is still the most robust and reliable manner to pick the best raw material candidates, but it requires the use of large numbers of animals and is time-consuming and expensive. Therefore, we are developing an platform that can provide a reliable evaluation of new ingredients. The main aim of this work was to combine an digestion protocol of extruded, commercially relevant aquafeeds with the exposure of intestinal epithelial cells to the extracted bio-available fraction (BAF). The results show that 250,000 cells/cm represents the optimal seeding density and that up to 50% BAF concentration for up to 24 h had no negative effects on the epithelial barrier morphology and function. It is possible to determine amino acid digestibility and bioavailability in all the experimental conditions (with and without BSA, at 25% and 50% dilution) and at all time points (0, 6, and 24 h). However, BAF concentration, the medium used for its dilution, and the length of exposure to the different epithelial cell lines can all influence the results and, therefore, must be selected according to the final aim of the experiment.

Citing Articles

New Insights in Microplastic Cellular Uptake Through a Cell-Based Organotypic Rainbow-Trout () Intestinal Platform.

Verdile N, Cattaneo N, Camin F, Zarantoniello M, Conti F, Cardinaletti G Cells. 2025; 14(1.

PMID: 39791745 PMC: 11719976. DOI: 10.3390/cells14010044.


Metabolic disrupting chemicals in the intestine: the need for biologically relevant models: Zebrafish: what can we learn from this small environment-sensitive fish?.

Erradhouani C, Bortoli S, Ait-Aissa S, Coumoul X, Brion F FEBS Open Bio. 2024; 14(9):1397-1419.

PMID: 39218795 PMC: 11492336. DOI: 10.1002/2211-5463.13878.


Distinct Organotypic Platforms Modulate Rainbow Trout () Intestinal Cell Differentiation In Vitro.

Verdile N, Camin F, Pavlovic R, Pasquariello R, Stuknyte M, De Noni I Cells. 2023; 12(14).

PMID: 37508507 PMC: 10377977. DOI: 10.3390/cells12141843.

References
1.
Borenfreund E, Puerner J . Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett. 1985; 24(2-3):119-24. DOI: 10.1016/0378-4274(85)90046-3. View

2.
Fedi A, Vitale C, Ponschin G, Ayehunie S, Fato M, Scaglione S . In vitro models replicating the human intestinal epithelium for absorption and metabolism studies: A systematic review. J Control Release. 2021; 335:247-268. DOI: 10.1016/j.jconrel.2021.05.028. View

3.
Brodkorb A, Egger L, Alminger M, Alvito P, Assuncao R, Ballance S . INFOGEST static in vitro simulation of gastrointestinal food digestion. Nat Protoc. 2019; 14(4):991-1014. DOI: 10.1038/s41596-018-0119-1. View

4.
Minghetti M, Drieschner C, Bramaz N, Schug H, Schirmer K . A fish intestinal epithelial barrier model established from the rainbow trout (Oncorhynchus mykiss) cell line, RTgutGC. Cell Biol Toxicol. 2017; 33(6):539-555. PMC: 5658468. DOI: 10.1007/s10565-017-9385-x. View

5.
Xu Y, Shrestha N, Preat V, Beloqui A . An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers. Adv Drug Deliv Rev. 2021; 175:113795. DOI: 10.1016/j.addr.2021.05.005. View